PH25905A - A controlled release pharmaceutical dosage form - Google Patents

A controlled release pharmaceutical dosage form

Info

Publication number
PH25905A
PH25905A PH3772A PH3772A PH25905A PH 25905 A PH25905 A PH 25905A PH 3772 A PH3772 A PH 3772A PH 3772 A PH3772 A PH 3772A PH 25905 A PH25905 A PH 25905A
Authority
PH
Philippines
Prior art keywords
dosage form
controlled release
medicament
pharmaceutical dosage
release pharmaceutical
Prior art date
Application number
PH3772A
Other languages
English (en)
Inventor
Masayoshi Samejima
Shigeyuki Ishikawa
Kazuo Noda
Masao Kobayashi
Original Assignee
Masayoshi Samejima
Shigeyuki Ishikawa
Kazuo Noda
Masao Kobayashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masayoshi Samejima, Shigeyuki Ishikawa, Kazuo Noda, Masao Kobayashi filed Critical Masayoshi Samejima
Publication of PH25905A publication Critical patent/PH25905A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH3772A 1987-11-06 1988-11-04 A controlled release pharmaceutical dosage form PH25905A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28118987 1987-11-06

Publications (1)

Publication Number Publication Date
PH25905A true PH25905A (en) 1991-12-19

Family

ID=17635585

Family Applications (1)

Application Number Title Priority Date Filing Date
PH3772A PH25905A (en) 1987-11-06 1988-11-04 A controlled release pharmaceutical dosage form

Country Status (24)

Country Link
US (1) US4963365A (fr)
EP (1) EP0315414B1 (fr)
KR (1) KR940002655B1 (fr)
CN (1) CN1035099C (fr)
AT (1) ATE68343T1 (fr)
AU (1) AU610275B2 (fr)
BG (1) BG60638B1 (fr)
CA (1) CA1331565C (fr)
DE (1) DE3865631D1 (fr)
DK (1) DK175249B1 (fr)
ES (1) ES2027013T3 (fr)
FI (1) FI96273C (fr)
FR (1) FR2622799B1 (fr)
GR (1) GR3002915T3 (fr)
HK (1) HK44593A (fr)
HU (1) HU201468B (fr)
IE (1) IE60785B1 (fr)
IL (1) IL88083A (fr)
NO (1) NO176233C (fr)
PH (1) PH25905A (fr)
PT (1) PT88945B (fr)
RU (1) RU1816213C (fr)
SG (1) SG15493G (fr)
ZA (1) ZA888147B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
ES2044246T3 (es) * 1989-02-11 1994-01-01 Bayer Ag Medicamentos con liberacion controlada del producto activo.
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
WO1990011074A1 (fr) * 1989-03-22 1990-10-04 Pang Peter K T Facteur hypertensif de la parathyroide
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
DK0585355T3 (da) * 1991-05-20 1995-06-06 Tanabe Seiyaku Co Flerlagspræparat med reguleret frigivelse
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
DE69327745T2 (de) * 1992-05-29 2000-09-21 Nikken Chemicals Co., Ltd. Tablette zur langsamen Freisetzung von Natriumvalproat
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
TW477708B (en) * 1996-09-13 2002-03-01 Shionogi & Amp Co Use of the thermal change to produce a substained release preparations and a process for their production
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
KR100396171B1 (ko) * 1998-08-10 2003-08-27 아사히 가세이 가부시키가이샤 염산 파수딜의 경구 서방성 제제
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6946146B2 (en) 2001-04-18 2005-09-20 Nostrum Pharmaceuticals Inc. Coating for a sustained release pharmaceutical composition
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
CA2529984C (fr) 2003-06-26 2012-09-25 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
CN1296046C (zh) * 2003-12-23 2007-01-24 广州市医药工业研究所 盐酸地尔硫䓬控释胶囊剂及其制备方法
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007092717A1 (fr) * 2006-02-07 2007-08-16 Fmc Corporation Revêtements de compositions de latex ou de pseudo latex et procédé associé
EP2007360B1 (fr) 2006-04-03 2014-11-26 Isa Odidi Dispositif d'administration à libération commandée comprenant un enrobage organosol
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US8927010B2 (en) * 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) * 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10292937B2 (en) * 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
EP2529731A1 (fr) * 2011-06-01 2012-12-05 Nitto Denko Corporation Préparation de particules et son procédé de production
FR2996418B1 (fr) * 2012-10-09 2015-05-29 Seppic Sa Compositions alimentaires comprenant des capsules obtenues par coacervation ne mettant pas en œuvre de reticulant toxique
WO2014078435A1 (fr) 2012-11-14 2014-05-22 W. R. Grace & Co.-Conn. Compositions contenant un matériau biologiquement actif et un oxyde inorganique non ordonné

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1172087A (fr) * 1956-01-25 1959-02-05 Bellon Labor Sa Roger Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4390406A (en) * 1982-07-23 1983-06-28 Allied Corporation Replaceable outer junction double junction reference electrode
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Also Published As

Publication number Publication date
US4963365A (en) 1990-10-16
IE883246L (en) 1989-05-06
NO884947D0 (no) 1988-11-04
KR890007720A (ko) 1989-07-05
DK618088A (da) 1989-05-07
DK618088D0 (da) 1988-11-04
IL88083A (en) 1992-11-15
EP0315414A1 (fr) 1989-05-10
AU610275B2 (en) 1991-05-16
IE60785B1 (en) 1994-08-10
HUT50624A (en) 1990-03-28
NO884947L (no) 1989-05-08
PT88945A (pt) 1989-11-30
FI96273B (fi) 1996-02-29
EP0315414B1 (fr) 1991-10-16
FI885101A (fi) 1989-05-07
FR2622799A1 (fr) 1989-05-12
CN1035099C (zh) 1997-06-11
AU2472788A (en) 1989-05-11
SG15493G (en) 1993-04-16
PT88945B (pt) 1993-05-31
ATE68343T1 (de) 1991-11-15
DK175249B1 (da) 2004-07-19
FI885101A0 (fi) 1988-11-04
BG85941A (bg) 1993-12-24
GR3002915T3 (en) 1993-01-25
KR940002655B1 (ko) 1994-03-28
NO176233B (no) 1994-11-21
CN1033007A (zh) 1989-05-24
ES2027013T3 (es) 1992-05-16
HK44593A (en) 1993-05-14
FI96273C (fi) 1996-06-10
HU201468B (en) 1990-11-28
FR2622799B1 (fr) 1991-11-29
BG60638B1 (bg) 1995-11-30
CA1331565C (fr) 1994-08-23
IL88083A0 (en) 1989-06-30
NO176233C (no) 1995-03-01
RU1816213C (ru) 1993-05-15
ZA888147B (en) 1990-06-27
DE3865631D1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
PH25905A (en) A controlled release pharmaceutical dosage form
IE891006L (en) Controlled release pharmaceutical preparation
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
GB2181053B (en) Pharmaceutical formulations with controlled release of the active substance
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
SG103391G (en) Pharmaceutical formulations with controlled release of the active substance
BE895805A (fr) Nouvel heptadecapeptide a effet de liberation d'hormone de croissance et medicament le contenant
ZA867507B (en) Pharmaceutical formulations with controlled release of the active substance